These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Ezetimibe: caution in the face of doubt]. Araujo F; Mateo de Castro J; Encinas Barrios C Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227 [No Abstract] [Full Text] [Related]
23. Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics. Leonard CE; Han X; Bilker WB; Flory JH; Brensinger CM; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S Diabetes Res Clin Pract; 2016 May; 115():60-7. PubMed ID: 27242124 [TBL] [Abstract][Full Text] [Related]
24. Cholesterol reduction, statins and the cytochrome P-450 system. No more recipes please. Bortolini M Eur Heart J; 2001 Aug; 22(16):1514-6. PubMed ID: 11482929 [No Abstract] [Full Text] [Related]
25. Clinical decision making on statin drug interactions. Williams CD J Am Coll Cardiol; 2003 Jul; 42(2):396-7; author reply 397-8. PubMed ID: 12875792 [No Abstract] [Full Text] [Related]
26. Drug-drug interactions: how scared should we be? Shapiro LE; Shear NH CMAJ; 1999 Nov; 161(10):1266-7. PubMed ID: 10584089 [No Abstract] [Full Text] [Related]
28. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis. Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558 [TBL] [Abstract][Full Text] [Related]
29. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials. Geng Q; Ren J; Chen H; Lee C; Liang W Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878 [TBL] [Abstract][Full Text] [Related]
30. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials. Geng Q; Ren J; Chen H; Lee C; Liang W Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122 [TBL] [Abstract][Full Text] [Related]
31. Possible mechanisms of interaction between statins and vitamin D. Bhattacharyya S; Bhattacharyya K; Maitra A QJM; 2012 May; 105(5):487-91. PubMed ID: 22323613 [No Abstract] [Full Text] [Related]
32. Statin-fibrate combination for mixed dyslipidaemia: a limited option? Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP Curr Med Res Opin; 2010 Sep; 26(9):2137-40. PubMed ID: 20662560 [TBL] [Abstract][Full Text] [Related]
33. Statin-induced focal myositis of the upper extremity. A report of two cases. Wagner M; Mühldorfer-Fodor M; Prommersberger KJ; Schmitt R Eur J Radiol; 2011 Feb; 77(2):258-60. PubMed ID: 21232890 [TBL] [Abstract][Full Text] [Related]
34. Lipid-lowering effects of ezetimibe and simvastatin in combination. Ijioma N; Robinson JG Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210 [TBL] [Abstract][Full Text] [Related]
35. Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin. Khandwala HM South Med J; 2006 Dec; 99(12):1385-7. PubMed ID: 17233196 [TBL] [Abstract][Full Text] [Related]
36. Antiretroviral and statin drug-drug interactions. Ray GM Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370 [TBL] [Abstract][Full Text] [Related]
37. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population. Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557 [TBL] [Abstract][Full Text] [Related]
38. Medications for cholesterol: which statin is best. Harv Mens Health Watch; 2004 Nov; 9(4):1-4. PubMed ID: 15556909 [No Abstract] [Full Text] [Related]
39. [Mechanisms of hepatotoxicity]. Bertolami MC Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():25-7. PubMed ID: 16400394 [TBL] [Abstract][Full Text] [Related]
40. Cheilitis due to treatment with simvastatin. Mehregan DR; Mehregan DA; Pakideh S Cutis; 1998 Oct; 62(4):197-8. PubMed ID: 9798110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]